These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 237418)

  • 1. Letter: Stability of erythromycin gluceptate in sodium chloride injection and dextrose injection.
    Bergstrom RF; Fites AL
    Am J Hosp Pharm; 1975 Mar; 32(3):241. PubMed ID: 237418
    [No Abstract]   [Full Text] [Related]  

  • 2. Stability of ganciclovir sodium in 5% dextrose injection and in 0.9% sodium chloride injection over 35 days.
    Parasrampuria J; Li LC; Stelmach AH; Sykes TR; Gordon GA
    Am J Hosp Pharm; 1992 Jan; 49(1):116-8. PubMed ID: 1570851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of dobutamine hydrochloride and verapamil hydrochloride in 0.9% sodium chloride and 5% dextrose injections.
    Das Gupta V; Stewart KR
    Am J Hosp Pharm; 1984 Apr; 41(4):686-9. PubMed ID: 6720710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of ranitidine hydrochloride at dilute concentration in intravenous infusion fluids at room temperature.
    Galante LJ; Stewart JT; Warren FW; Johnson SM; Duncan R
    Am J Hosp Pharm; 1990 Jul; 47(7):1580-4. PubMed ID: 2368751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of methylprednisolone sodium succinate in 5% dextrose and 0.9% sodium chloride injections.
    Pyter RA; Hsu LC; Buddenhagen JD
    Am J Hosp Pharm; 1983 Aug; 40(8):1329-33. PubMed ID: 6351604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of milrinone in 0.45% sodium chloride, 0.9% sodium chloride, or 5% dextrose injections.
    Wilson TD; Forde MD; Crain AV; Dombrowski LJ; Joyce MA
    Am J Hosp Pharm; 1986 Sep; 43(9):2218-20. PubMed ID: 3766576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability and sorption of FK 506 in 5% dextrose injection and 0.9% sodium chloride injection in glass, polyvinyl chloride, and polyolefin containers.
    Taormina D; Abdallah HY; Venkataramanan R; Logue L; Burckart GJ; Ptachcinski RJ; Todo S; Fung JJ; Starzl TE
    Am J Hosp Pharm; 1992 Jan; 49(1):119-22. PubMed ID: 1373936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of urokinase diluted in 0.9% sodium chloride injection or 5% dextrose injection and stored in glass or plastic syringes.
    Patel JP; Tran LT; Sinai WJ; Carr LJ
    Am J Hosp Pharm; 1991 Jul; 48(7):1511-4. PubMed ID: 1882883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of concentrated trimethoprim-sulfamethoxazole admixtures.
    Jarosinski PF; Kennedy PE; Gallelli JF
    Am J Hosp Pharm; 1989 Apr; 46(4):732-7. PubMed ID: 2785757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of acetazolamide sodium in 5% dextrose or 0.9% sodium chloride injection.
    Parasrampuria J; Das Gupta V; Stewart KR
    Am J Hosp Pharm; 1987 Feb; 44(2):358-60. PubMed ID: 3565398
    [No Abstract]   [Full Text] [Related]  

  • 12. Stability of metoprolol tartrate in 5% dextrose injection or 0.9% sodium chloride injection.
    Belliveau PP; Shea BF; Scavone JM
    Am J Hosp Pharm; 1993 May; 50(5):950-2. PubMed ID: 8506875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of amphotericin B in four concentrations of dextrose injection.
    Wiest DB; Maish WA; Garner SS; el-Chaar GM
    Am J Hosp Pharm; 1991 Nov; 48(11):2430-3. PubMed ID: 1746578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of an ofloxacin injection in various infusion fluids.
    Bornstein M; Kao SH; Mercorelli M; Verma S
    Am J Hosp Pharm; 1992 Nov; 49(11):2756-60. PubMed ID: 1335206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compatibility of ketorolac tromethamine injection with common infusion fluids and administration sets.
    Floy BJ; Royko CG; Fleitman JS
    Am J Hosp Pharm; 1990 May; 47(5):1097-100. PubMed ID: 2337102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of formulation and sterilisation conditions on the stability of half-strength darrows in 2.5% w/w dextrose solution to autoclaving.
    Watkins WM; Sixsmith DG; Kibaya M
    East Afr Med J; 1982 Feb; 59(2):127-32. PubMed ID: 7128497
    [No Abstract]   [Full Text] [Related]  

  • 17. Stability of cisplatin, iproplatin, carboplatin, and tetraplatin in commonly used intravenous solutions.
    Cheung YW; Cradock JC; Vishnuvajjala BR; Flora KP
    Am J Hosp Pharm; 1987 Jan; 44(1):124-30. PubMed ID: 3548341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of zidovudine in 5% dextrose injection and 0.9% sodium chloride injection.
    Lam NP; Kennedy PE; Jarosinski PF; Gallelli JF
    Am J Hosp Pharm; 1991 Feb; 48(2):280-2. PubMed ID: 2003500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of vancomycin hydrochloride in 5% dextrose and 0.9% sodium chloride injections.
    Das Gupta V; Stewart KR; Nohria S
    Am J Hosp Pharm; 1986 Jul; 43(7):1729-31. PubMed ID: 3752110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of pentamidine isethionate in 5% dextrose and 0.9% sodium chloride injections.
    De NC; Alam AS; Kapoor JN
    Am J Hosp Pharm; 1986 Jun; 43(6):1486-8. PubMed ID: 3728484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.